[ Price : $8.95]
FDA advises manufacturers that they should develop vaccines with a monovalent XBB.1.5 composition, according to a notice posted on...[ Price : $8.95]
Reps. Schiff and Kuster introduce legislation to direct FDA to establish a process to allow generic drug manufacturers to update d...[ Price : $8.95]
FDAs Vaccines and Related Biological Products Advisory Committee votes 21 to 0 that the Covid-19 vaccination program for the 2023-...[ Price : $8.95]
FDA researchers discuss ways to improve the use of AI/ML in precision medicine.[ Price : $8.95]
Corvus Pharmaceuticals seeks a 3rd quarter meeting with FDA to discuss a Phase 3 trial for its investigational cancer drug CPI-818...[ Price : $8.95]
Harvard Medical School professor Jerry Avorn says FDA needs to take a nonbinary approach to some drug approvals with a conditional...[ Price : $8.95]
FDA clears a Phase 3 protocol amendment to allow a time-based analysis of Glycomimetics uproleselan if sufficient survival events ...[ Price : $8.95]
Public Citizens Health Research Group urges FDA to not grant accelerated approval to Sarepta Therapeutics gene therapy SRP-9001 fo...